Nitric oxide/carbon monoxide: A molecular switch for myocardial preservation during ischemia

Circulation

Volumn 94, Issue 9 SUPPL., 1996, Pages

  Maulik, Nilanjana ^a   Engelman, Daniel T ^a   Watanabe, Masazumi ^a   Engelman, Richard M ^b   Rousou, John A ^b   Flack III, Joseph E ^b   Deaton, David W ^b   Gorbunov, Nikolai V ^c   Elsayed, Nabil M ^d   Kagan, Valerian E ^c   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

carbon monoxide; heme oxygenase; ischemia; nitric oxide; reperfusion

Indexed keywords

ARGININE; BILIRUBIN; CARBON MONOXIDE; CYCLIC GMP; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; LACTATE DEHYDROGENASE; MALONALDEHYDE; MESSENGER RNA; METHYLENE BLUE; NITRIC OXIDE; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; BILIRUBIN; CARBON MONOXIDE; CYCLIC GMP; FREE RADICAL SCAVENGERS; HEART; HEME OXYGENASE (DECYCLIZING); LIPID PEROXIDATION; MALE; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; ORGAN PRESERVATION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 10244222264     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Das DK, Engelman RM. Phospholipids in myocardial reperfusion injury. In: Das DK, ed. Pathophysiology of Reperfusion Injury. Boca Raton, Fla: CRC Press; 1993:149-179.
2. 2+ channel and calmodulin receptor inhibition. Heart Vessels. 1992;7: 189-195.
3. Otani H, Engelman RM, Breyer RH, Rousou JA, Lemeshow S, Das DK. Mepacrine, a phospholipase inhibitor: a potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg. 1986;92:247-254.
4. Bredt DS, Snyder SH. Nitric oxide: a physiological messenger molecule. Annu Rev Biochem. 1994;63:175-195.
5. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. L-Arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg. 1995;60:1275-1281.
6. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74:3203-3207.
7. Zhuo M, Small SA, Kandel ER, Hawkins RD. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science. 1993;260:1946-1950.
8. Fukushima T, Okinaga S, Sekizawa K,Ohrui T, Yamaya M, Sasaki H. Cyclic GMP formation in rat cerebellar slices is stimulated by endothelins via nitric oxide formation and by sarafotoxins via formation of carbon monoxide. Biochemistry. 1994;25:652-665.
9. Hawkins RD, Zhuo M, Arancio O. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation. J Neurobiol. 1994;25:652-665.
10. Llesuy SF, Tomaro ML. Heme oxygenase and oxidative stress: evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta. 1994;1223:9-14.
11. Massoudy P, Becker BF, Gerlach E. Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart. J Cardiovasc Pharmacol. 1995;25:440-447.
12. Hiramatsu T, Forbess JM, Miura T, Mayer JE. Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. J Thorac Cardiovasc Surg. 1995;109:81-87.
13. Schluter KD, Weber M, Schraven WE, Piper HM. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Am J Physiol. 1994;267:H1461-H1466.
14. Konorev EA, Tarpey MM, Joseph J, Baker JE, Kalyanaraman B. S-Nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest: evidence for a cardioprotective effect of nitric oxide. J Pharmacol Exp Ther. 1995;274:200-206.
15. Pernow J, Uriuda Y, Wang Q-D, Li X-S, Nordlander R, Rydeen L. The protective effect of L-arginine on myocardial injury and endothelial function following ischemia and reperfusion in the pig. Eur Heart J. 1994;15:1712-1719.
16. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC III, McGee S, Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol. 1992;263:1650-1658.
17. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection of organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther. 1992;260:668-675.
18. Maulik N, Sharma HS, Das DK. Induction of the heme oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol. 1996;28:1261-1270.
19. Shraga-Levine Z, Galron R, Sokolovsky M. cGMP formation in rat cerebellar slices is stimulated by endothelins via nitric oxide formation and by sarafotoxins via formation of carbon monoxide. Biochemistry. 1994;33:14656-14659.
20. Kalfin R, Maulik N, Engelman RM, Cordis GA, Milenov K, Kasakov L, Das DK. Protective role of intracoronary vasoactive intestinal peptide in ischemic reperfused myocardium. J Pharmacol Exp Ther. 1994;268:952-958.
21. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Kisin E, Kagan VE, Maulik N, Das DK. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res. 1995; 29:133-140.
22. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Constitutive nitric oxide release is impaired following ischemia and reperfusion. J Thorac Cardiovasc Surg. 1995;110:1047-1053.
23. Maulik N, Engelman DT, Watanabe M, Engelman RM, Maulik G, Cordis GA, Das DK. Nitric oxide signaling in ischemic heart. Cardiovasc Res. 1995;30:593-601.
24. Cordis GA, Maulik N, Das DK. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol. 1995;27:1645-1653.
25. Maulik N, Engelman RM, Wei Z, Lu D, Rousou JA, Das DK. Interleukin-1α preconditioning reduces myocardial ischemia reperfusion injury. Circulation. 1993;88(suppl II):II-387-II-394.
26. Galaris D, Cadenas E, Hochstein P. Redox cycling of myoglobin and ascorbate: a potential protective mechanism against oxidative reperfusion injury in muscle. Arch Biochem Biophys. 1989;273:497-504.
27. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker-Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991;181:1392-1397.
28. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A. 1993;90:13-17.
29. Wittenberg JB. Myoglobin-facilitated oxygen diffusion: role of myoglobin in oxygen entry into muscle. Physiol Rev. 1970;50:559-636.
30. Galaris D, Cadenas E, Hochstein P. Redox cycling of myoglobin and ascorbate: a potential protective mechanism against oxidative reperfusion injury in muscle. Arch Biochem Biophys. 1989;273:497-504.
31. Hogg N, Rice-Evans C, Darley-Usmar V, Wilson MT, Paganga G, Dourne L. The role of lipid hydroperoxides in myoglobin-dependent oxidation of LDL. Arch Biochem Biophys. 1994;314:39-44.
32. Davidge SD, Baker PN, McLaughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 1995;77:274-283.
33. Otani H, Engelman RM, Rousou JA, Breyer RH, Das DK. Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. J Mol Cell Cordiol. 1986;18:953-960.
34. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem. 1991;60:553-575.
35. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res. 1977;3:23-35.
36. Ignarro LJ, Adams JB, Horwitz PM, Wood KS. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange: comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem. 1986;261:4997-5002.
37. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cGMP signal transduction system. Adv Pharmacol. 1994;26:19-33.
38. Trong HL, Beier N, Sonnenburg WK, Stroop SD, Walsh KA, Beavo JA, Charbonneau H. Amino acid sequence of the cyclic GMP stimulated cyclic nucleotide phosphodiesterase from bovine heart. Biochemistry. 1990;29:10280-10288.
39. Das DK, Engelman RM, Prasad MR, Rousou JA, Breyer RH, Jones R, Young H, Cordis GA. Improvement of ischemia-reperfusion induced myocardial dysfunction by modulating calcium overload using a novel specific calmodulin antagonist, CGS 9343B. Biochem Pharmacol. 1989;38:465-471.
40. Das DK, Moraru II, Maulik N, Engelman RM. Gene expression during myocardial adaptation to ischemia and reperfusion. Ann N Y Acad Sci. 1994;723:292-308.
41. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993;259:381-384.
42. Stone JR, Marletta MA. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 1994;33: 5636-5640.